Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.
公司代碼BFRI
公司名稱Biofrontera Inc
上市日期Oct 14, 2021
CEOLuebbert (Hermann)
員工數量92
證券類型Ordinary Share
年結日Oct 14
公司地址120 Presidential Way,
城市WOBURN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01801
電話17812451325
網址https://www.biofrontera-us.com/
公司代碼BFRI
上市日期Oct 14, 2021
CEOLuebbert (Hermann)